84.57
BATS BZX Real-Time Price
As of 3:42pm ET
 +0.43 / +0.51%
Today’s Change
69.18
Today|||52-Week Range
99.84
-10.69%
Year-to-Date
Bristol-Myers' Acquisition of Bluebird Seems to Make Sense
Oct 20 / GuruFocus News - Paid Partner Content
Top Research Reports for Novartis, Zoom Video & FIS
Oct 16 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Files for Rinvoq in Atopic Dermatitis in US & EU
Oct 20 / Zacks.com - Paid Partner Content
Roche's (RHHBY) 9M20 Sales Affected by COVID-19 Outbreak
Oct 15 / Zacks.com - Paid Partner Content
Gilead's (GILD) CAR T Cell Therapy Gets Positive CHMP Opinion
Oct 19 / Zacks.com - Paid Partner Content
Pfizer's (PFE) Ibrance Fails in Early Breast Cancer Study
Oct 12 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Novartis, Zoom Video, FIS, 3M and TOTAL
Oct 19 / Zacks.com - Paid Partner Content
Model N (MODN) Announces Upbeat Preliminary Results for Q4
Oct 09 / Zacks.com - Paid Partner Content
Alnylam (ALNY) Gets Positive CHMP Opinion for Lumasiran
Oct 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close84.14
Today’s open84.93
Day’s range84.04 - 84.61
Volume1,110,855
Average volume (3 months)1,736,341
Market cap$197.4B
Data as of 3:42pm ET, 10/22/2020

Growth & Valuation

Earnings growth (last year)-43.54%
Earnings growth (this year)+6.42%
Earnings growth (next 5 years)+10.35%
Revenue growth (last year)-8.60%
P/E ratio26.9
Price/Sales4.62
Price/Book3.52

Competitors

 Today’s
change
Today’s
% change
MRKMerck+1.26+1.61%
PFEPfizer+0.41+1.11%
ABBVAbbVie+1.42+1.71%
AZNAstraZeneca+0.37+0.72%
Data as of 3:42pm ET, 10/22/2020

Financials

Next reporting dateOctober 27, 2020
EPS forecast (this quarter)$1.45
Annual revenue (last year)$47.5B
Annual profit (last year)$7.0B
Net profit margin15.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts